Prenatal flaw test maker hit with a suit for false positives

By Jonathan Capriel (February 18, 2022, 6:57 PM EST) — Genetic testing company Natera Inc. knowingly sold and marketed unreliable prenatal tests to doctors and pregnant women that falsely indicated that healthy fetuses had serious birth defects, sometimes resulting in abortions, according to a proposed class action lawsuit filed in California federal court on Thursday.

Women use these non-invasive prenatal tests, known as NIPT, to detect chromosomal disorders. Although largely accurate at detecting Down syndrome, the lawsuit claims the tests often give false positives for “rare genetic conditions”. These inaccurate results can cause unnecessary mental anguish for parents and result in additional costs for additional medical visits and counseling, the lawsuit says.

“A fake…

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
  • Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and more!

TRY LAW360 FREE FOR SEVEN DAYS

Comments are closed.